Dong Wha Pharm Overview
- Year Founded
-
1897
- Status
-
Public
- Employees
-
846
- Stock Symbol
-
000020
- Investments
-
8
- Share Price
-
$3.63
- (As of Friday Closing)
Dong Wha Pharm General Information
Description
Dongwha Pharm Co Ltd is engaged in manufacturing and selling pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/ respiratory system, muscle relaxant/musculoskeletal system, nervous system, and dermatological/urinary system among several other products.
Contact Information
Website
www.dong-wha.co.krCorporate Office
- Building 1897, 20 Seosomun-ro 9-gil, Jung-gu
- Seoul, Jung 04516
- South Korea
Corporate Office
- Building 1897, 20 Seosomun-ro 9-gil, Jung-gu
- Seoul, Jung 04516
- South Korea
Dong Wha Pharm Stock Performance
As of 20-Nov-2026, Dong Wha Pharm’s stock price is $3.63. Its current market cap is $101M with 27.7M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.63 | $3.73 | $3.03 - $5.08 | $101M | 27.7M | 239K | $0.44 |
Dong Wha Pharm Financials Summary
As of 30-Sep-2026, Dong Wha Pharm has a trailing 12-month revenue of $357M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 186,316 | 206,498 | 162,669 | 150,523 |
| Revenue | 357,086 | 348,803 | 340,708 | 276,193 |
| EBITDA | 26,369 | 21,976 | 20,006 | 36,641 |
| Net Income | 12,237 | 6,103 | 4,077 | 20,986 |
| Total Assets | 480,144 | 445,947 | 420,670 | 433,405 |
| Total Debt | 87,485 | 82,232 | 65,846 | 36,549 |
Dong Wha Pharm Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Dong Wha Pharm Patents
Dong Wha Pharm Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026139915-A1 | Novel carboxamide derivative compound and pharmaceutical composition comprising same | Pending | 26-Dec-2024 | ||
| WO-2025053515-A1 | Cosmetic composition containing culture solutions of fusarium corneum and streptococcus sp. strains and use thereof | Inactive | 04-Sep-2023 | ||
| WO-2025053514-A1 | Reverse-phase liposome containing culture medium of fusidium corneum and use thereof | Inactive | 04-Sep-2023 | ||
| AU-2024332189-A1 | Novel lactic acid bacteria and use thereof | Pending | 01-Sep-2023 | ||
| EP-4772609-A1 | Novel lactic acid bacteria and use thereof | Pending | 01-Sep-2023 | C12N1/205 |
Dong Wha Pharm Signals
Dong Wha Pharm Investments & Acquisitions (8)
Dong Wha Pharm’s most recent deal was a Corporate Asset Purchase with Celltrion (4 Types of Over the Counter Drugs). The deal was made on 19-Jan-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Celltrion (4 Types of Over the Counter Drugs) | 19-Jan-2024 | Corporate Asset Purchase | Buildings and Property | ||
| Trung Son Alpha | 03-Aug-2023 | Merger/Acquisition | Specialty Retail | ||
| Fitpet | 21-Mar-2023 | Later Stage VC | Other Services (B2C Non-Financial) | ||
| HAII | 23-Nov-2022 | Later Stage VC | Other Healthcare Technology Systems | ||
| ORGANOID SCIENCES | 13-Jan-2022 | Early Stage VC | Drug Discovery |
Dong Wha Pharm ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Dong Wha Pharm Exits (1)
Dong Wha Pharm’s most recent exit was on 01-Oct-2018 from Next Biomedical. The exit was categorized as with 6 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Next Biomedical | 01-Oct-2018 | Completed |
|
Dong Wha Pharm Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Medyssey | Jecheon, South Korea | 2003 | |
| Trung Son Alpha | Can Tho, Vietnam | 1997 |
Dong Wha Pharm FAQs
-
When was Dong Wha Pharm founded?
Dong Wha Pharm was founded in 1897.
-
Where is Dong Wha Pharm headquartered?
Dong Wha Pharm is headquartered in Seoul, South Korea.
-
What is the size of Dong Wha Pharm?
Dong Wha Pharm has 846 total employees.
-
What industry is Dong Wha Pharm in?
Dong Wha Pharm’s primary industry is Pharmaceuticals.
-
Is Dong Wha Pharm a private or public company?
Dong Wha Pharm is a Public company.
-
What is Dong Wha Pharm’s stock symbol?
The ticker symbol for Dong Wha Pharm is 000020.
-
What is the current stock price of Dong Wha Pharm?
As of 20-Nov-2026 the stock price of Dong Wha Pharm is $3.63.
-
What is the current market cap of Dong Wha Pharm?
The current market capitalization of Dong Wha Pharm is $101M.
-
What is Dong Wha Pharm’s current revenue?
The trailing twelve month revenue for Dong Wha Pharm is $357M.
-
What is Dong Wha Pharm’s annual earnings per share (EPS)?
Dong Wha Pharm’s EPS for 12 months was $0.44.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process